QUOTE AND NEWS
StreetInsider.com  10 hrs ago  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sinovac+%28SVA%29+Gets+Fourth+H1N1+Vaccine+Order+from+Chinese+Government/5147830.html for the full story.
China and Asia Stock Alert - Global Wealth Report  Nov 26  Comment 
I had talked about the Chinese vaccine maker Sinovac (NYSE:SVA) before in positive terms but warned that they were already at peak production and therefore had very little upside. Well...Sinovac solved that problem by creating a joint venture...
StreetInsider.com  Nov 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sinovac+%28SVA%29+Executes+Joint+Venture+Agreement+to+Establish+Sinovac+Dalian+Vaccine+Technology+Co./5139765.html for the full story.
PR Newswire  Nov 24  Comment 
BEIJING, Nov. 24 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that management is scheduled to present at the Piper Jaffray Health Care Conference on Wednesday,
StreetInsider.com  Nov 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Sinovac+Biotech+%28SVA%29+Files+10M+Share+Shelf/5121266.html for the full story.
PR Newswire  Nov 17  Comment 
BEIJING, Nov. 17 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China, announced today that it received a revised production license from State Food and Drug Administration for Panflu.1, the
StreetInsider.com  Nov 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Piper+Jaffray+Upgrades+Sinovac+Biotech+Ltd.+%28SVA%29+to+Overweight%3B+Raises+PT+%26+Estimates/5111126.html for the full story.
StreetInsider.com  Nov 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sinovac+Bio+%28SVA%29+Selected+by+Shanghai+Government+to+Supply+Hep+A+Vaccine/5110013.html for the full story.
China Securities  Nov 15  Comment 
BEIJING, Nov. 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading developer and provider of vaccines, announced today its unaudited financial results for the three-month and nine-month periods ended September 30,...
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
SVA AT A GLANCE
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki